Zhou Caiyu, Wang Qian, Jiang Jing, Gao Lizeng
CAS Engineering Laboratory for Nanozyme, Institute of Biophysics, Chinese Academy of Sciences, Beijing 100101, China.
College of Life Sciences, Graduate School of University of Chinese Academy of Sciences, Beijing 100049, China.
Antibiotics (Basel). 2022 Mar 15;11(3):390. doi: 10.3390/antibiotics11030390.
Infectious diseases caused by bacteria represent a global threat to human health. However, due to the abuse of antibiotics, drug-resistant bacteria have evolved rapidly and led to the failure of antibiotics treatment. Alternative antimicrobial strategies different to traditional antibiotics are urgently needed. Enzyme-based antibacterials (Enzybiotics) have gradually attracted interest owing to their advantages including high specificity, rapid mode-of-action, no resistance development, etc. However, due to their low stability, potential immunogenicity, and high cost of natural enzymes, enzybiotics have limitations in practical antibacterial therapy. In recent years, many nanomaterials with enzyme-like activities (Nanozymes) have been discovered as a new generation of artificial enzymes and perform catalytic antibacterial effects against bacterial resistance. To highlight the progress in this field of nanozyme-based antibacterials (Nanozybiotics), this review discussed the antibacterial mechanism of action of nanozybiotics with a comparison with enzybiotics. We propose that nanozybiotics may bear promising applications in antibacterial therapy, due to their high stability, rapid bacterial killing, biofilm elimination, and low cost.
由细菌引起的传染病对人类健康构成全球威胁。然而,由于抗生素的滥用,耐药菌迅速进化,导致抗生素治疗失效。迫切需要不同于传统抗生素的替代抗菌策略。基于酶的抗菌剂(酶抗菌剂)因其高特异性、快速作用方式、无耐药性产生等优点而逐渐引起关注。然而,由于其稳定性低、潜在免疫原性以及天然酶成本高,酶抗菌剂在实际抗菌治疗中存在局限性。近年来,许多具有类酶活性的纳米材料(纳米酶)被发现作为新一代人工酶,并对细菌耐药性发挥催化抗菌作用。为突出基于纳米酶的抗菌剂(纳米酶抗菌剂)这一领域的进展,本综述讨论了纳米酶抗菌剂的抗菌作用机制,并与酶抗菌剂进行了比较。我们认为,纳米酶抗菌剂因其高稳定性、快速杀菌、消除生物膜以及低成本等特点,在抗菌治疗中可能具有广阔的应用前景。
Antibiotics (Basel). 2022-3-15
Int J Biol Macromol. 2024-10
Front Chem. 2024-9-23
Wiley Interdiscip Rev Nanomed Nanobiotechnol. 2022-3
Adv Exp Med Biol. 2019
Chembiochem. 2020-9-1
Colloids Surf B Biointerfaces. 2021-2
Colloids Surf B Biointerfaces. 2020-11
Int J Nanomedicine. 2022
RSC Adv. 2024-11-20
J Nanobiotechnology. 2024-11-13
Bioact Mater. 2024-9-4
Nat Commun. 2024-7-5
J Nanobiotechnology. 2024-4-25
Antibiotics (Basel). 2024-1-25
J Nanobiotechnology. 2023-11-15
ACS Appl Mater Interfaces. 2021-12-29
Mater Sci Eng C Mater Biol Appl. 2021-12
ACS Appl Mater Interfaces. 2021-11-17
Nano Lett. 2021-11-24